Figure 5.
Astrocytic hApoEε4 potentiates MC1 pathology produced by tau oligomers. Scale bar of representative images represents 50 µM. High-content imaging and associated quantification represents data from one independent experiment. (a) Immunocytochemistry of co-cultures five days after addition with 100 nM of tau monomers or tau oligomers. Oligomers were added five days after transduction with the PGFAP construct of interest. Cells were fixed and stained with MC1 to measure tau pathology and MAP2 to label neurons. Hoechst stain was used to label nuclei. Arrowheads highlight examples of MC1-positive cell bodies and neurites. Top panel depicts images without MAP2 imaging overlay to aid in visualization. (b) High-content imaging to quantify MAP2-positive Hoechst-labeled nuclei (n = 4 wells/group). (c,d) Quantification of MC1 intensity (c) and MC1 area (d) in MAP2-labeled cell bodies (n = 4 wells/group). Data were normalized to the oligomer-treated PGFAP::EV group (n = 4 wells/group). NS not significant, *p < 0.05, **p < 0.01, Tukey multiple comparisons test following one-way ANOVA.